Back to Journals » Biologics: Targets and Therapy » Volume 17

Biologics: Targets and Therapy

ISSN: 1177-5491


Archive: Volume 17, 2023

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis

van Leeuwen JR, Popov T, Obergfell A, Rabelink TJ, Teng YKO

Biologics: Targets and Therapy 2023, 17:11-14

Published Date: 25 January 2023

Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices

Haroon MM, Hegazy GA, Hassanien MA, Shaker O, Hussein WH

Biologics: Targets and Therapy 2023, 17:1-9

Published Date: 18 January 2023